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ABSTRACT
Enterobacter gergoviae is a gram negative rod-shaped opportunistic organism reported to cause urinary and respiratory 
tract infections, but peritonitis caused by this organism is unknown. We report a case of 50-year-old patient on 
peritoneal dialysis (PD) presented with Enterobacter gergoviae peritonitis with septic shock.  Despite Intraperitoneal 
(IP) cloxacillin 250mg qid and IP ceftazidime 1gram q24h and subsequent escalation with IP amikacin 2mg/kg q24h 
and IP vancomycin 15mg/kg q24h within the next 48 hours, his peritonitis remained refractory and required catheter 
removal. Although Enterobacter gergoviae is naturally sensitive to aminoglycosides, carbapenems and quinolones, it 
reacts differently to the beta lactam antibiotics. Their resistance to third-generation cephalosporins is fast emerging 
and treatment with third-generation cephalosporins may cause AmpC-overproducing mutants. The majority of 
Enterobacteriaceae, including Extended-spectrum beta-lactamases producers, remain susceptible to carbapenems. 
Our report provides an unfavourable course of E. gergoviae peritonitis likely due to acquired secondary drug 
resistance during the therapy period. 
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INTRODUCTION
Peritonitis remains a major complication of peritoneal 
dialysis (PD) patients; accounting up to 18% of 
infection-related mortality in PD patients. They usually 
present with turbid effluent, abdominal signs, cell count 
of white blood cells more than 100/mL with at least 50% 
polymorphonuclear neutrophilic cells and a positive 
culture. Enterobacter gergoviae, an opportunistic 
organism has been reported to cause urinary and 
respiratory tract infection (1), but peritonitis caused by 
this organism is yet to be reported in the literature. We 
present the first case of Enterobacter gergoviae peritonitis 
in patient receiving peritoneal dialysis.
CASE REPORT
We report a case of 50 year-old man patient with a past 
medical history of vascular access exhaustion and had 
been converted to PD for the past 2 years without any 
problem. On this occasion, he travelled from another 
state to visit his relative who resided near our hospital. 
After two days, he presented to Serdang Hospital with 
symptoms of fever, abdominal pain, diarrhea and turbid 
PD fluid. Upon presentation he was febrile and in septic 
shock requiring single inotropic support. Intraperitoneal 
(IP) cloxacillin 250mg qid and IP ceftazidime 1 gram 
q24h was given upon admission as per our department 
guidelines. His initial PD fluid cell count revealed 5425 
cells/mm3(majority polymorphs), peripheral WBC 18 
x 109/L and his C-reactive protein was 280 mg/L. IP 
amikacin 2mg/kg q24h was added within the next 24 
hours as his PD fluid was still turbid with cell count 
showing slight improvement at 2400 cells/mm3. Despite 
that he responded poorly even with the addition of the 
second line antibiotic within the next 24 hours. On the 
fourth day of admission his PD fluid was still turbid 
with cell counts remained high at 1060 cells/mm3. IP 
vancomycin 15mg/kg q24h was then added on. Despite 
this, he was still requiring inotropes and his PD fluid 
was still not clearing up even after 5 days of intensified 
antibiotics. The peritoneal dialysis catheter was removed 
in view of the refractory peritonitis. Within 24 hours of 
catheter removal, patient’s clinical condition improved 
tremendously, we were able to wean off the inotropes 
and his abdominal symptoms resolved fully. Cultures of 
the PD fluid subsequently came back as Enterobacter 
gergoviae; sensitive to augmentin, ampicillin, amikacin, 
ceftazidime, cefoperazone, ciprofloxacin, cefotaxime, 
cefuroxime and gentamicin. His peripheral blood 
cultures yielded no growth. 
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He admitted that his relative’s home where he did his 
PD exchanges were not as ideal as his home set up 
condition. There was no dedicated corner for him to 
perform the exchanges and the washing basin facility is 
relatively far from the place he did the exchanges. 
After the PD catheter was removed, the patient responded 
well to the same antibiotics and returned to good health 
within the next 48 hours. We continued the antibiotics 
for 2 weeks in the hospital and discharge him with an 
oral course of ciprofloxacin for 1 week, making the total 
duration of treatment 3 weeks. Upon review in clinic 2 
weeks later, he was in good health and is now receiving 
hemodialysis via a cuffed catheter. 
DISCUSSION
Enterobacter gergoviae (E. gergoviae) belongs to the 
family Enterobacteriaceae. It is a gram negative rod-
shaped organism which was first described by Richard 
et al in 1976, isolated from urinary samples taken 
during a urinary infection outbreak in Clermont-Ferrand 
University Hospital near Gergoviae Highland in France 
(2). It is an opportunistic pathogen of the urinary tract and 
has been associated with antibiotic-resistant outbreaks 
in hospitals. Apart from urinary tract, this microbe is 
also frequently isolated from the respiratory tract and 
from blood. In a case of nosocomial outbreak in a 
neonatal intensive care unit, the strain was isolated from 
the dextrose saline used for the dilution of parenteral 
antibiotics and from the hands of a healthcare worker 
on duty (3). Enterobacter species can also be isolated 
from natural environments, such as sewage, soil, and 
foods. It has also been reportedly isolated from cosmetic 
products. Very little is known regarding this organism 
and its clinical significance is not yet known. To the best 
of our knowledge, there has been no peritonitis cases 
reported to be cause by this organism. 
Antibiotic susceptibility of the Enterobacter species 
have been the subject of interest as many sought to 
provide more data on the newer taxa of the enterobacter 
species. The natural resistance of all species to 
rifampicin, lincosamide, glycopeptides and fusidic 
acid is well known and is largely attributed to the outer 
membrane of these bacteria (4). The enterobacter group 
is naturally sensitive to tetracycline, aminoglycosides, 
carbapenems and quinolones. They however react 
differently to beta lactam antibiotics. E. gergoviae has 
intermediate sensitivity to amoxicillin and amoxicillin/
clavulanic acid, naturally sensitive or intermediate to 
most cephalosopins except cefoxitin in which they are 
naturally resistant to (5). Resistance of Enterobacter spp 
to third-generation cephalosporins is fast emerging and 
this is mostly associated with overproduction of AmpC 
beta-lactamases, and treatment with third-generation 
cephalosporins may select for AmpC-overproducing 
mutants. Some Enterobacter strains are now ESBL and 
AmpC producers, conferring resistance to both third- 
and fourth-generation cephalosporins. Quinolone 
resistance in Enterobacteriaceae is usually the result 
of chromosomal mutations leading to alterations in 
target enzymes or drug accumulation. The vast majority 
of Enterobacteriaceae, including ESBL producers, 
remain susceptible to carbapenems, and these agents 
are considered preferred empiric therapy for serious 
Enterobacteriaceae infections. Carbapenem resistance, 
although rare, appears to be increasing.
Despite detecting the organism early (within day 3 of 
admission) and treating with the appropriate antibiotics 
with adequate therapeutic dose, his peritonitis remained 
refractory which lead to catheter removal. E. gergoviae 
has likely acquired secondary drug resistance during the 
therapy period. Peritoneal dialysis catheter removal is 
needed in cases of refractory peritonitis as the catheter 
itself can serve as the nidus of infection. Removal of 
catheter will also protect the peritoneum for future 
reinitiation of PD.
CONCLUSIONS
As there was no previous reported E. gergoviae PD 
peritonitis, our report provides an unfavourable natural 
course of E. gergoviae peritonitis despite prescribing 
the appropriate antibiotics. Although an opportunistic 
infection, Enterobacter species are either very resistant 
to many agents or can acquire resistance during 
antimicrobial therapy as likely what had happened 
in our case, the choice of appropriate antimicrobial 
agents is complicated. Hence carbapenems should 
come as a strong consideration when there is failure 
for E. gergoviae peritonitis to respond adequately with 
our usual repertoire of antibiotics. Consultation with 
experts in infectious diseases and microbiology will 
be beneficial in such case. The case also highlighted 
the importance of constant reminding our PD patient 
regarding the important of hand hygiene and cleanliness 
of the surrounding environment where PD exchanges 
are being carried out.
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